MSA Chief Science Officer to Serve on the PhRMA Foundation Study Review Section.

Posted on:

Dr Ken Dretchen , MSA Chief Science Officer, has been invited to sit on the Pharmaceutical Research Manufacturers of America (PhRMA) Foundation study section. Beginning November 2, 2015  Dr. Dretchen will assume his role in the study section where he will  review and advise the Foundation on pre-doctoral, post-doctoral and research starter grant applications. This appointment continues our colleagues continued recognition as a most  important industry leader and as a pharmaceutical scientist.  We at MSA remain in admiration of our friend and colleague and we are proud of the routine recognition he receives from our industry.